CLINICAL_TRIALS
trial_result
· 2017-03-21
Clinical Trial Update: CyberKnife for Unresectable Renal Tumors [NA]
Summary
A completed clinical trial evaluating CyberKnife radiosurgery for unresectable renal tumors (kidney cancer).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Beth Israel Deaconess Medical Center | Conditions: Renal Cancer | NA | Status: COMPLETED